Join us during these five consecutive months from September to January on our pursuit for giving insight on how the zebrafish is utilized as an in-vivo model and a tool for drug discovery and BioReperias zebrafish tumor xenograft (ZTX) model.
The BioReperia team is excited to present its webinar series titled
Something smells fishy: Removing doubts – Zebrafish an exceptional translational in-vivo tool for drug development and personalized medicine in cancer
In this third live webinar on the 19th of November, the the co-founder and CTO of BioReperia Dr Jensen will talk about how targeting tumor dissemination and metastasis is made possible using ZTX models, and why it is important to consider this as a part of early anticancer drug discovery and development.
To evaluate local invasion, vascular dissemination and metastasis from a primary tumor the Zerbafish ZTX model is a perfect in vivo tool. Due to the rapid development of the zebrafish embryo and therefore vascularization of the implanted tumors, evaluation can be made at single-cell resolution, and over time, in a living organism. Recent data coupling dissemination and metastasis in ZTX models created from patient tumor biopsies or PDX models to the actual lymphatic dissemination and metastasis of the patients demonstrated that the ZTX-models are accurate models of this process.
Speaker
Malin Vildevall, PhD
BioReperia, CSO
Webinar language: English
—————————————————————
Please join our webinars by
Registering for Part 1: https://app.livestorm.co/bioreperia/2021event3
Registration for all upcoming events: https://app.livestorm.co/bioreperia
If problem registering, please try a different web browser
—————————————————————